(Q34632502)

3 August 2017

1 reference

title

The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

1

Tadeusz Robak

1 reference

3 August 2017

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

43

1 reference

3 August 2017

537-548

1 reference

3 August 2017

3

1 reference

Management of chronic lymphocytic leukaemia

3 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Key issues in the treatment of chronic lymphocytic leukaemia (CLL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Cladribine in the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Cladribine (2-chlorodeoxyadenosine)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Pentostatin therapy of T-cell lymphomas with cutaneous manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Fludarabine therapy in hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Infectious and immunosuppressive complications of purine analog therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290012029

10.1080/10428190290012029

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12002757